Pliant Therapeutics (PLRX) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Pliant Therapeutics (PLRX) over the last 6 years, with Q3 2025 value amounting to -$0.43.
- Pliant Therapeutics' EPS (Weighted Average and Diluted) rose 5473.68% to -$0.43 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.87, marking a year-over-year increase of 1407.19%. This contributed to the annual value of -$3.47 for FY2024, which is 2632.29% down from last year.
- According to the latest figures from Q3 2025, Pliant Therapeutics' EPS (Weighted Average and Diluted) is -$0.43, which was up 5473.68% from -$0.71 recorded in Q2 2025.
- Over the past 5 years, Pliant Therapeutics' EPS (Weighted Average and Diluted) peaked at -$0.43 during Q3 2025, and registered a low of -$0.95 during Q3 2024.
- For the 5-year period, Pliant Therapeutics' EPS (Weighted Average and Diluted) averaged around -$0.74, with its median value being -$0.71 (2025).
- In the last 5 years, Pliant Therapeutics' EPS (Weighted Average and Diluted) tumbled by 5957.45% in 2021 and then skyrocketed by 5473.68% in 2025.
- Quarter analysis of 5 years shows Pliant Therapeutics' EPS (Weighted Average and Diluted) stood at -$0.68 in 2021, then dropped by 5.88% to -$0.72 in 2022, then grew by 4.17% to -$0.69 in 2023, then decreased by 19.06% to -$0.82 in 2024, then skyrocketed by 47.66% to -$0.43 in 2025.
- Its last three reported values are -$0.43 in Q3 2025, -$0.71 for Q2 2025, and -$0.92 during Q1 2025.